When managing anxiety, many individuals face a choice between medication such as Xanax and therapeutic approaches like Exposure and Response Prevention (ERP). Xanax, a benzodiazepine, works by enhancing the brain's production and effects of GABA, a neurotransmitter that calms nervous activity, providing quick relief during acute anxiety or panic attacks. However, while effective for symptom management, Xanax may only offer temporary relief and does not address the underlying causes of anxiety disorders. On the other hand, ERP therapy employs a research-backed method where patients gradually confront feared situations without engaging in avoidance behaviors. This approach helps patients develop stronger coping skills and build confidence over time. Unlike medication, ERP targets the root causes by retraining the brain to handle anxiety-provoking stimuli, which can result in more lasting improvement. Side effects differ significantly between treatments. Xanax may cause drowsiness, dependence, or withdrawal symptoms if discontinued abruptly, whereas ERP may induce temporary discomfort but no long-term physical side effects. Importantly, relapse rates tend to be higher when treatment relies solely on medication, as symptoms often return once the drug is stopped. ERP fosters relapse prevention skills by teaching patients to manage uncertainty and resist compulsions. Considering this, combining medication with therapy may offer balanced benefits — medication for immediate symptom relief and therapy for sustainable recovery. Consulting with a psychiatrist or mental health professional is crucial to develop a personalized treatment plan that addresses both symptom management and the root causes of anxiety disorders.